Table 1.

Patient characteristics and outcomes

Characteristics/clinical outcomes
Patients, n	72
Female, n (%)	30 (42)
Age, median (range)	39 (18–70)
Weight, median, kg	76
Prior diagnosis, n (%)	66 (92)
Disease extent at diagnosis, n (%)	E3–30 (42)
	E2–32 (44)
	E1–10 (14)
5‐ASA prior to admission, n (%)	41 (57)
Immunomodulator prior	15 (21)
Biologic prior	15 (21)
CRP on admission, median	38
Albumin on admission, median	33
Endoscopic severity on admission, n (%)	M1–3 (4)
	M2–29 (40)
	M3–40 (56)
Median length of stay, n, days (IQR)	6 (5–10)
Infliximab salvage, n (%)	34 (47)
Infliximab at 1 year, n (%)	32 (44)
Vedolizumab at 1 year, n (%)	12 (17)
Colectomy during index admission, n (%)	4 (6)
Colectomy at 1 year, n (%)	10 (14)